02/13/2020
11:45 AM | Flynn James E (Filed by)
Kalvista Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/07/2020
4:18 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
4:17 PM | Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
4:14 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:32 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
4:30 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
6:34 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
6:32 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2019
3:30 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2019
4:26 PM | Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2019
4:25 PM | Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2019
4:24 PM | Kalvista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2019
3:00 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2019
4:23 PM | Kalvista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
3:18 PM | Kalvista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/09/2019
3:15 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2019
6:20 AM | Kalvista Pharmaceuticals (Filer)
| Form DEF 14A
| |
07/30/2019
6:37 PM | Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2019
4:53 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2019
4:52 PM | Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2019
5:38 PM | Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2019
5:52 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2019
3:20 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2019
6:15 AM | Kalvista Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
07/16/2019
5:50 AM | Kalvista Pharmaceuticals (Filer)
| Form NT 10-K
| |
07/01/2019
3:15 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
4:36 PM | Edwards Martin (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
4:35 PM | Edwards Martin (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2019
4:50 PM | Kalvista Pharmaceuticals (Issuer)
Smith Michael David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/17/2019
4:44 PM | Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
4:34 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
4:29 PM | Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
4:22 PM | Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
4:17 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2019
3:42 PM | Kalvista Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A
| |
04/24/2019
3:41 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2019
4:33 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
4:30 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
4:29 PM | Kalvista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
4:27 PM | Kalvista Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/22/2019
4:58 PM | Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2019
5:30 PM | Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2019
3:35 PM | Kalvista Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A
| |
04/10/2019
6:21 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2019
4:33 PM | Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
2:27 PM | Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
| Form SC 13D/A
| |
04/02/2019
5:57 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
4:25 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2019
4:22 PM | Kalvista Pharmaceuticals (Filer)
| Form 424B5
| |
03/28/2019
4:29 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2019
3:43 PM | Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
| Form SC 13D/A
| |
03/20/2019
3:13 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2019
3:08 PM | Kalvista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management II, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2019
7:03 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:52 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2019
3:44 PM | Kalvista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2019
3:16 PM | Kalvista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/06/2019
8:05 AM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2019
7:30 AM | Kalvista Pharmaceuticals (Subject)
SVLSF IV, LLC (Filed by)
| Form SC 13D/A
| |
02/21/2019
1:35 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
4:41 PM | Kalvista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2019
4:39 PM | Kalvista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/01/2019
3:30 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2019
5:53 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
6:48 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2019
6:44 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4/A
| |
01/18/2019
4:42 PM | Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2019
5:25 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
4:12 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
6:10 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2018
11:16 PM | Kalvista Pharmaceuticals (Filer)
| Form EFFECT
| |
12/21/2018
3:19 PM | Kalvista Pharmaceuticals (Issuer)
SV Life Sciences Fund IV , L.P. (0001422340) (Reporting)
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. (Reporting)
SV LIFE SCIENCES FUND IV, L.P. (Reporting)
SVLSF IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2018
4:17 PM | Kalvista Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/14/2018
3:16 PM | Kalvista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/14/2018
6:53 AM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2018
5:08 PM | Kalvista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
5:07 PM | Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
5:05 PM | Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
5:03 PM | ALDRICH RICHARD (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2018
3:00 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2018
3:00 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2018
6:35 PM | Kalvista Pharmaceuticals (Issuer)
Maetzel Andreas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
6:33 PM | Feener Edward P. (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
6:31 PM | Kalvista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
6:29 PM | Kalvista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
6:26 PM | Crockett Thomas Andrew (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2018
3:11 PM | Kalvista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/12/2018
6:16 PM | Kalvista Pharmaceuticals (Issuer)
ORONSKY ARNOLD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2018
6:11 PM | Cha Albert (Reporting)
Kalvista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2018
3:32 PM | Kalvista Pharmaceuticals (Subject)
Vivo Ventures VI, LLC (Filed by)
| Form SC 13G
| |
09/10/2018
3:30 PM | Kalvista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A
| |
09/10/2018
3:27 PM | Kalvista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners II, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings II, LLC (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management II, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2018
8:59 PM | Kalvista Pharmaceuticals (Filer)
| Form 424B5
| |
09/06/2018
3:02 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2018
4:03 PM | Kalvista Pharmaceuticals (Filer)
| Form 424B5
| |
08/15/2018
3:10 PM | Kalvista Pharmaceuticals (Filer)
| Form DEF 14A
| |
08/09/2018
3:33 PM | Kalvista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G
| |
08/01/2018
3:59 PM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2018
3:46 PM | Kalvista Pharmaceuticals (Filer)
| Form 424B5
| |
07/31/2018
7:30 AM | Kalvista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
